Correct, what I was alluding to is that the licensing company would eventually absorb PAA rather than continue paying royalties. Particularly as there is the possibility of other neurological applications.
100 million per year in royalties would probably result in a conservative Cap of 500 - 1 billion dollars. Either way we win, we just need MPL to continue kicking goals.
Exciting times.
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow), page-42
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |